
Biogen Inc. is a leading multinational biotechnology company headquartered in Cambridge, Massachusetts, USA. Founded in 1978, Biogen is dedicated to discovering, developing, and delivering innovative therapies for the treatment of neurological and neurodegenerative diseases, including multiple sclerosis (MS), Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and spinal muscular atrophy (SMA). With a mission to improve the lives of patients worldwide, Biogen has established itself as a pioneer in neuroscience research and a trusted partner in the biopharmaceutical industry.
Employing over 7,500 people globally, Biogen operates in multiple countries and maintains a strong market presence through its portfolio of approved therapies and robust pipeline of investigational drugs. The company is widely recognized for its groundbreaking work in MS treatments and its advancements in gene therapy and biosimilars. In recent years, Biogen has garnered significant attention for its development of aducanumab, a controversial but landmark therapy for Alzheimer's disease, marking a major milestone in the pursuit of disease-modifying treatments for neurodegenerative disorders.
No open positions at Biogen right now. Check back later!
Browse All Jobs →